Table 3 Clinical outcomes of gynecomastia patients who received single-port 3-dimensional (3D) endoscopic-assisted subcutaneous mastectomy
Gynecomastia patients (N = 10) | |
Age, years, N ( %) | |
< 40 | 9 (90) |
≧ 40, < 60 | 1 (10) |
≧ 60 | 0 |
Mean ± SD | 27.2 ± 6.7 |
BMI, kg/m2, N (%) | |
< 18 | 0 |
18–24 | 2 (20) |
> 24 | 8 (80) |
Grade of gynecomastiaa, N (%) | |
Grade I (small enlargement without skin excess) | 2 (20) |
Grade IIa (moderate enlargement without skin excess) | 7 (70) |
Grade IIb (moderate enlargement with minor skin excess) | 1 (10) |
Grade III (marked enlargement with excess skin and ptosis) | 0 |
Perioperative parameters for bilateral subcutaneous mastectomy | Mean ± SD (median, range) |
Total operation time, min | 310 ± 70 (312.5, 205–440) |
Blood loss, ml | 57.5 ± 35.8 (50, 30–150) |
Mastectomy specimen weight, g | 436.4 ± 261 (445.25, 140–931) |
Length of hospital stay, days | 1.8 ± 0.6 (2, 1–3) |
Follow-up durations, months, mean ± SD (median, range) | 3.3 ± 4.2 (1.5, 0–14) |